Drug intelligence / Profile preview

allosamidin

Development stage
Discontinued
Lead developer
Ajinomoto
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01

Overview

Allosamidin is a small molecule natural product and a potent inhibitor of family 18 chitinases, originally isolated as a secondary metabolite from Streptomyces species. It exhibits strong inhibitory activity against chitinases from various sources, including fungi such as Candida albicans and Coccidioides immitis, with nanomolar potency. The compound acts as a competitive inhibitor by binding to the active site of chitinase enzymes, interfering with their ability to hydrolyze chitin. Allosamidin has been explored for its potential use as an antifungal agent due to its inhibition of fungal chitinases and has also been investigated for possible applications in asthma therapy and as a pesticide. Its mechanism involves direct interaction with catalytic residues in the enzyme active site, stabilizing an inactive conformation[2][3][4][5][9].

Other names
allosamidin(-)-allosamidine
02

Targets

CHIT1 (Chitotriosidase)

Beyond the preview

Go deeper on allosamidin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allosamidin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call